Showing results (21-30 of 90) with videos related to

Sort By:
Pageof 9
BMC Health Services Research|February 16, 2023
"There's a big tag on my head": exploring barriers to treatment seeking with women who use methamphetamine in Sydney, AustraliaBrendan Clifford, Kate Van Gordon, Fiona Magee, et al.
BMJ Open|May 19, 2021
Safety and tolerability of oral lisdexamfetamine in adults with methamphetamine dependence: a phase-2 dose-escalation studyNadine Ezard, Brendan Clifford, Adrian Dunlop, et al.
The International Journal on Drug Policy|June 1, 2022
Controlling for pleasure and risk: The experiences of sexuality and gender diverse people who use GHBJack Freestone, Garrett Prestage, Adam Bourne, et al.
Frontiers in Psychiatry|February 5, 2026
Digital health interventions for people who use methamphetamine: a scoping reviewKathryn Fletcher, Jack Freestone, Brendan Clifford, et al.
European Journal of Public Health|June 24, 2019
Alcohol use among conflict-affected persons in Ukraine: risk factors, coping and access to mental health servicesAnu Ramachandran, Nino Makhashvili, Jana Javakhishvili, et al.
Drug and Alcohol Review|October 21, 2022
Phenobarbital to manage severe gamma-hydroxybutyrate withdrawal: A case seriesGeorgia Freeman, Krista J Siefried, Darren M Roberts, et al.
Drug and Alcohol Review|April 18, 2018
A managed alcohol program in Sydney, Australia: Acceptability, cost-savings and non-beverage alcohol useNadine Ezard, Michael E Cecilio, Brendan Clifford, et al.
The International Journal on Drug Policy|April 16, 2018
Substance Use and Sex Index (SUSI): First stage development of an assessment tool to measure behaviour change in sexualised drug use for substance use treatment studiesNadine Ezard, Beatrice Webb, Brendan Clifford, et al.
Drug and Alcohol Review|July 15, 2023
Methamphetamine and emerging drugs of concern: A training needs analysis of Australian alcohol and other drug helplinesFlorence Bascombe, Krista J Siefried, Brendan Clifford, et al.
The International Journal on Drug Policy|July 26, 2016
Alprazolam use and related harm among opioid substitution treatment clients - 12 months follow up after regulatory reschedulingRachel M Deacon, Suzanne Nielsen, Stefanie Leung, et al.
Pageof 9